Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 12, 2004, Pages 1103-1112

  McGuire, John J ^a,c   Hollenberg, Morley D ^a   Bennett, Brian M ^b   Triggle, Chris R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Blood vessels; Endothelium; Hyperpolarization; Protease activated receptor 2; Proteinase activated receptor 2; Transgenic mice; Vascular smooth muscle; Vasoactive peptides

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); APAMIN; BARIUM; CHARYBDOTOXIN; CIRAZOLINE; GUANYLATE CYCLASE INHIBITOR; INDOMETACIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; OUABAIN; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 2 AGONIST; SERYLLEUCYLGLYCYLARGINYLLEUCINAMIDE; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPOLARIZATION; ELECTROPHYSIOLOGY; ENZYME ACTIVATION; HYPERPOLARIZATION; MALE; MEMBRANE POTENTIAL; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL POLARITY; CYCLIC AMP; ELECTROPHYSIOLOGY; ISOMETRIC CONTRACTION; MALE; MEMBRANE POTENTIALS; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NA(+)-K(+)-EXCHANGING ATPASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROSTAGLANDINS; RECEPTOR, PAR-2; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION;

EID: 14844320457     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y04-121     Document Type: Article

References (38)

1. Busse, R., Edwards, G., Feletou, M., Fleming, I., Vanhoutte, P.M., and Weston, A.H. 2002. EDHF: bringing the concepts together. Trends Pharmacol. Sci. 23: 374-380.
2. Cenac, N., Coelho, A.M., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W.K. et al. 2002. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161: 1903-1915.
3. Chauhan, S.D., Nilsson, H., Ahluwalia, A., and Hobbs, A.J. 2003. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc. Natl. Acad. Sci. USA, 100: 1426-1431.
4. Cicala, C. 2002. Protease activated receptor 2 and the cardiovascular system. Br. J. Pharmacol. 135: 14-20.
5. Compton, S.J., McGuire, J.J., Saifeddine, M., and Hollenberg, M.D. 2002. Restricted ability of human mast cell tryptase to activate proteinase-activated receptor-2 in rat aorta. Can. J. Physiol. Pharmacol. 80: 987-992.
6. Damiano, B.P., Cheung, W.M., Santulli, R.J., Fung-Leung, W.P., Ngo, K., Ye, R.D. et al. 1999. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J. Pharmacol. Exp. Ther. 288: 671-678.
7. Ding, H., Kubes, P., and Triggle, C. 2000. Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase. Br. J. Pharmacol. 129: 1194-1200.
8. Edwards, G., Dora, K.A., Gardener, M.J., Garland, C.J., and Weston, A.H. 1998. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature, 396: 269-272.
9. Ellis, A., Pannirselvam, M., Anderson, T.J., and Triggle, C.R. 2003. Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery. Br. J. Pharmacol. 140: 1193-1200.
10. Ferrell, W.R., Lockhart, J.C., Kelso, E.B., Dunning, L., Plevin, R., Meek, S.E. et al. 2003. Essential role for proteinase-activated receptor-2 in arthritis. J. Clin. Investig. 111: 35-41.
11. Griffith, T.M., Chaytor, A.T., Taylor, H.J., Giddings, B.D., and Edwards, D.H. 2002. cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctions. Proc. Natl. Acad. Sci. USA, 99: 6392-6397.
12. Hamilton, J.R., Moffatt, J.D., Frauman, A.G., and Cocks, T.M. 2001. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries. J. Cardiovasc. Pharmacol. 38: 108-119.
13. Harper, J.F., and Brooker, G. 1975. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2′0 acetylation by acetic anhydride in aqueous solution. J. Cyclic Nucleotide Res. 1: 207-218.
14. Hollenberg, M.D., and Compton, S.J. 2002. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol. Rev. 54: 203-217.
15. Hollenberg, M.D., Saifeddine, M., Al Ani, B., and Kawabata, A. 1997. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can. J. Physiol. Pharmacol. 75: 832-841.
16. Kawabata, A., Nakaya, Y., Kuroda, R., Wakisaka, M., Masuko, T., Nishikawa, H., and Kawai, K. 2003. Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats. Br. J. Pharmacol. 140: 247-254.
17. Komori, K., Lorenz, R.R., and Vanhoutte, P.M. 1988. Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am. J. Physiol. 255: H207-H212.
18. Matoba, T., and Shimokawa, H. 2003. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. J. Pharmacol. Sci. 92: 1-6.
19. Matoba, T., Shimokawa, H., Nakashima, M., Hirakawa, Y., Mukai, Y., Hirano, K. et al. 2000. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J. Clin. Investig. 106: 1521-1530.
20. McGuire, J.J. 2004. Proteinase-Activated Receptor 2 (PAR2): A challenging new target for treatment of vascular diseases. Curr. Pharm. Des. 10: 2769-2778.
21. McGuire, J.J., and Triggle, C.R. 2003. Searching for the physiological role and therapeutic potential of vascular Proteinase-Activated Receptor 2. Drug Dev. Res. 60: 14-19.
22. McGuire, J.J., Anderson, D.J., and Bennett, B.M. 1994. Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate. J. Pharmacol. Exp. Ther. 271: 708-714.
23. McGuire, J.J., Ding, H., and Triggle, C.R. 2001. Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). Can. J. Physiol. Pharmacol. 79: 443-470.
24. McGuire, J.J., Hollenberg, M.D., Andrade-Gordon,P., and Triggle, C.R. 2002a. Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. Br. J. Pharmacol. 135: 155-169.
25. McGuire, J.J., Dai, J., Andrade-Gordon, P., Triggle, C.R., and Hollenberg, M.D. 2002b. Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2. J. Pharmacol. Exp. Ther. 303: 985-992.
26. McGuire, J.J., Gui, Y., Wang, X., Loutzenhiser, R.D., Triggle, C.R., and Hollenberg, M.D. 2003. Proteinase-Activated Receptor-2 (PAR2): Release of an Endothelium-Derived Hyperpolarizing Factor distinct from that released by acetylcholine. In EDHF 2002. Edited by P.M. Vanhoutte. Taylor & Francis, London, England. pp. 47-55.
27. McLean, P.G., Aston, D., Sarkar, D., and Ahluwalia, A. 2002. Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ. Res. 90: 465-472.
28. Nystedt, S., Emilsson, K., Wahlestedt, C., and Sundelin, J. 1994. Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. USA, 91: 9208-9212.
29. Pannirselvam, M., Verma S., Anderson, T.J., and Triggle, C.R. 2002. Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability. Br. J. Pharmacol. 136: 255-263.
30. Pannirselvam, M., Anderson, T.J., and Triggle, C.R. 2003a. Characterization of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from diabetic (db/db -/-) mice. In EDHF 2002. Edited by P.M. Vanhoutte. Taylor & Francis, London, England. pp. 124-131.
31. Pannirselvam, M., Anderson, T., and Triggle, C.R. 2003b. Endothelial cell dysfunction in Type I and II diabetes: The cellular basis for dysfunction. Drug Dev. Res. 58: 28-41.
32. Pawlinski, R., Pedersen, B., Schabbauer, G., Tencati, M., Holscher, T., Boisvert, W. et al. 2003. Role of tissue factor and protease activated receptors in a mouse model of endotoxemia. Blood, 103: 1342-1347.
33. Robin, J., Kharbanda, R., Mclean, P., Campbell, R., and Vallance, P. 2003. Protease-activated receptor 2-mediated vasodilatation in humans in vivo: role of nitric oxide and prostanoids. Circulation, 107: 954-959.
34. Schmidlin, F., Amadesi, S., Dabbagh, K., Lewis, D.E., Knott, P., Bunnett, N.W. et al. 2002. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J. Immunol. 169: 5315-5321.
35. Steiner, A.L., Parker, C.W., and Kipnis, D.M. 1972. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J. Biol. Chem. 247: 1106-1113.
36. Trottier, G., Hollenberg, M., Wang, X., Gui, Y., Loutzenhiser, K., and Loutzenhiser, R. 2002. PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions. Am. J. Physiol. Renal Physiol. 282: F891-F897.
37. Vu, T.K., Hung, D.T., Wheaton, V.I., and Coughlin, S.R. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64: 1057-1068.
38. Waldron, G.J., Ding, H., Lovren, F., Kubes, P., and Triggle, C.R. 1999. Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br. J. Pharmacol. 128: 653-658.